The central role of pathology labs in breast cancer precision oncology: a call for action

Multigenic tests represent an essential tool for the selection of adjuvant therapy in estrogen-positive/HER2-negative (ER + /HER2-) early breast cancer (BC). The workflow of these tests, either if they are externalized or carried out in-house, generates a workload for the pathology laboratories, tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pruneri, Giancarlo, Lorenzini, Daniele, Mastropasqua, Mauro G., Perrone, Giuseppe, Rizzo, Antonio, Santini, Donatella, Volpi, Chiara C., Cinieri, Saverio, Zambelli, Alberto, Sapino, Anna, Castellano, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876915/
https://www.ncbi.nlm.nih.gov/pubmed/36697419
http://dx.doi.org/10.1038/s41523-023-00506-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876915/
https://www.ncbi.nlm.nih.gov/pubmed/36697419
http://dx.doi.org/10.1038/s41523-023-00506-5

Ejemplares similares